Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy [PDF]
Clinics, 2017 OBJECTIVES: To investigate the association between diastolic function and the different beneficial effects of cardiac resynchronization therapy in patients with heart failure due to different causes.
Qi Wang +8 more
doaj +4 more sources
Electrocardiographic imaging metrics to predict the risk of arrhythmia in patients with ischemic cardiomyopathy [PDF]
Journal of ArrhythmiaBackground The leading cause of death in patients with ischemic cardiomyopathy is sudden cardiac death caused by ventricular arrhythmias. Accurate determination of arrhythmic risk in these patients is vital to allow clinicians to take appropriate ...
Azizah Puspitasari Ardinal +5 more
doaj +2 more sources
Left ventriculoplasty for ischemic cardiomyopathy [PDF]
European Journal of Cardio-Thoracic Surgery, 2001 In order to treat ischemic cardiomyopathy, which is defined as non-aneurysmal diffuse akinetic left ventricle with chronic heart failure following myocardial infarction, the mid-term effect of the endoventricular circular patch plasty (EVCPP) was studied.EVCPP has been performed on 54 patients (46 men and eight women with a mean age of 61 years) during
Hisayoshi Suma +3 more
openalex +4 more sources
Myocardial-alternation index (MMI) is correlated with soluble suppression of tumorigenecity-2 (sST2) in patients with ischemic cardiomyopathy [PDF]
The Egyptian Heart JournalBackground Ischemic cardiomyopathy is a condition that represents myocardial dysfunction due to obstructive coronary artery disease. In ischemic cardiomyopathy, both structural and electrical remodeling occur.
Andra Naufal Pramanda +4 more
doaj +2 more sources
Social Inequalities in Non-ischemic Cardiomyopathies [PDF]
Frontiers in Cardiovascular Medicine, 2022 Heart failure (HF) has various characteristics, such as etiology, clinical course, and clinical characteristics. Several studies reported the clinical findings of the characteristics of non-ischemic cardiomyopathy.
Eisuke Amiya, Eisuke Amiya
doaj +3 more sources
Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
Journal of Arrhythmia, 2017 Cardiac resynchronization therapy (CRT) using a biventricular pacing system has been an effective therapeutic strategy in patients with symptomatic heart failure with a reduced left ventricular ejection fraction (LVEF) of 35% or less and a QRS duration ...
Hisashi Yokoshiki, MD, PhD +4 more
doaj +3 more sources
Diagnosis of Turner syndrome after presenting with ischemic cardiomyopathy: A case report [PDF]
SAGE Open Medical Case ReportsUntreated Turner syndrome increases the risk of ischemic cardiomyopathy. We report a 44-year-old Chinese woman who was diagnosed with Turner syndrome owing to symptoms of ischemic cardiomyopathy and heart failure confirmed through cardiac magnetic ...
Hui Zheng +4 more
doaj +2 more sources
Ischemic and non-ischemic dilated cardiomyopathy
Open Medicine, 2014 Abstract Dilated Cardiomyopathy is a high-incident disease, which diagnosis of and treatments are clinical priority. The aim of our study was to evaluate the diagnostic potential of cardiac magnetic resonance (CMR) imaging; echocardiography and the biochemical parameters that can help us differentiate between the post-ischemic and non ...
Fazio Giovanni +5 more
doaj +5 more sources
Ischemic cardiomyopathy revealed by central retinal artery occlusion (CRAO) [PDF]
The Pan African Medical Journal, 2015 Here we report a case of central retinal artery occlusionrevealing an ischemic cardiomyopathy. A 54-year old smoker man presented at the hospital because of sudden visual loss in his left eye. There was cherry-red spot in the macula in his left eye.
Ihsen Zairi +9 more
doaj +4 more sources
Non-ischemic Cardiomyopathy Patients Derive Superior Mortality Benefit from Cardiac Resynchronization Therapy [PDF]
Indian Pacing and Electrophysiology Journal, 2007 Background: Cardiac Resynchronization Therapy (CRT) is indicated for the treatment of advanced heart failure with severe systolic dysfunction and intraventricular conduction delay. Patient selection for this technology is vital, though it remains unclear
Jonathan Rosman +4 more
doaj +3 more sources